#1 RAPT #2 CWCO
#1 LQDT #2 TSN #3 AXSM #4 GNE #5 MESA #6 CCLP #7 RIBT
The Trader: H&R Block Is Making a Comeback. Why It's Time to Buy the Stock. — Barron's Aug 11, 2023
BTIG Research Raises Jack Henry & Associates Price Target to $200 From $183, Maintains Buy Rating Jul 25, 2023
Factor Likely to Influence Dillard's (DDS) in Q2 Earnings Aug 3, 2023
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers.
Telos Wins $5.8 Million Contract From National Geospatial-Intelligence Agency Aug 1, 2023
KeyCorp (KEY) Q2 Earnings and Revenues Lag Estimates Jul 20, 2023
Kelly Services to Cut Jobs in Restructuring Jul 20, 2023
Earnings Flash (ADES) ADVANCED EMISSIONS SOLUTIONS Reports Q2 Revenue $20.4M, vs. Street Est of $17.3M Aug 9, 2023
Barings BDC (BBDC) Q2 Earnings and Revenues Top Estimates
BTIG Initiates ProKidney With Buy Rating, $16 Price Target Jul 25, 2023